// Company Overview //
| Stock Name | 朝聚眼科醫療控股有限公司 |
| Stock Code | 02219 |
| Company Full Name | 朝聚眼科醫療控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事經營眼科醫院及視光中心。 |
| Listing Date | 2021-07-07 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市豐臺區西三環南路14號院首科大廈A座東區24層 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | http://www.chaojueye.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Prospectus Date | 2021-06-24 |
| Offer Price | HK$ 10.60 / shares |
| Total Funds Raised | HK$ 905,929,000 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 10.6 |
| First Day Change | 33.02% |
| First Day Volume | 165726000.0 |
| First Day Turnover | 2121820000.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、約35.8%(或485.5百萬港元)將用于建立新醫院以及搬遷、升級及裝修現有醫院;
2、約44.8%(或608.4百萬港元)將在出現合適機遇時,用于在人口龐大且對眼科醫療服務需求相對較高的新市場中收購醫院;
3、約9.4%(或127.5百萬港元)將用于升級我們的信息技術系統;
4、約10.0%(或135.7百萬港元)將用于營運資金及其他一般企業用途。 |
// Underwriting Syndicate //
联席保荐人 (2)
海通国际资本有限公司
华泰金融控股(香港)有限公司
整体协调人 (2)
海通国际证券有限公司
华泰金融控股(香港)有限公司
联席账簿管理人 (2)
海通国际证券有限公司
华泰金融控股(香港)有限公司
联席牵头经办人 (2)
海通国际证券有限公司
华泰金融控股(香港)有限公司
// Cornerstone Investors //
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
Gigantic Wealth Holdings Limited |
155,205,200 HKD |
— |
8.57% |
— |
6 months |
2022-01-07 |
| 2 |
The Valliance Fund |
155,205,200 HKD |
— |
8.57% |
— |
6 months |
2022-01-07 |
| 3 |
富国基金管理有限公司 |
349,217,000 HKD |
— |
19.27% |
— |
6 months |
2022-01-07 |
| 4 |
通柏资本(香港)有限公司 |
131,922,300 HKD |
— |
7.28% |
— |
6 months |
2022-01-07 |
// Directors & Management //
| Chairman | 張波洲 |
| Company Secretary | 羅偉健;張光弟 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 張波洲及關連人士(14.08%);張小利(11.91%);王暉及關連人士(11.1%);Orchid Asia VII, L.P.(9.7%);張俊峰(8.47%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.